Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|8|944-953

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.8, 2011-10, pp. : 944-953

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

By Ahn Hee  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1768-1772

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene   Keating Gillian M.  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

By Abou-Alfa Ghassan K.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 4, 2009-04 ,pp. : 397-403

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 9, 2012-01 ,pp. : 1233-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song   He Qing  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite